Wednesday, March 11, 2020 11:51:09 PM
Enjoyed your recent posts. I think you bought at a good time. I reentered here around $1.70 and bought more today at $1.40. I may average down one more time if it continues to fall but I’m not sure yet.
Let’s keep this in perspective, only about ~$1m in dollar volume was traded in the past two days combined. If people want to sell far below value because the market is ripe with fear, they can (and will) go ahead. Cooler heads will prevail and my suspicion is that they will quickly. Earnings is coming up at the end of the month, and when people see the full year numbers compared to the market cap it’s trading at, I think that will reset us back in the right direction.
The sector isn’t constraining it is growing and when people realize that there are profitable and scalable business models like what we have here, they will be better late than never to invest.
Let’s keep this in perspective, only about ~$1m in dollar volume was traded in the past two days combined. If people want to sell far below value because the market is ripe with fear, they can (and will) go ahead. Cooler heads will prevail and my suspicion is that they will quickly. Earnings is coming up at the end of the month, and when people see the full year numbers compared to the market cap it’s trading at, I think that will reset us back in the right direction.
The sector isn’t constraining it is growing and when people realize that there are profitable and scalable business models like what we have here, they will be better late than never to invest.
Recent MEDIF News
- MediPharm Labs Positioned to Serve Growing U.S. Pharmaceutical and Clinical Research Demand Following Cannabis Rescheduling • GlobeNewswire Inc. • 04/27/2026 12:30:00 PM
- International Medical Sales Surge 43% as GMP Certified Producer Hits Global Growth Phase • AllPennyStocks.com • 03/30/2026 05:47:31 PM
- MediPharm Labs Reports Full Year & Fourth Quarter 2025 Results with Over 40% Annual Growth in International Medical Revenue • GlobeNewswire Inc. • 03/30/2026 11:45:00 AM
- MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2025 Financial Results • GlobeNewswire Inc. • 03/25/2026 11:05:48 PM
- MediPharm Labs Announces CEO Transition: David Pidduck to Step Down; CFO Greg Hunter Appointed Interim CEO • GlobeNewswire Inc. • 01/19/2026 01:00:00 PM
- MediPharm Labs to Enter New Market with Costa Rica Supply Agreement • GlobeNewswire Inc. • 01/13/2026 01:00:00 PM
- Historic U.S. Cannabis Rescheduling Unlocks Potential Growth Opportunities for MediPharm Labs, Backed by the Company's Suite of Licenses and Proven U.S. Clinical Trial Supply Experience • GlobeNewswire Inc. • 12/19/2025 01:45:00 PM
- MediPharm Labs Announces Board of Directors Changes: Shelley Potts Steps Down, Michael Bumby Returns • GlobeNewswire Inc. • 12/11/2025 01:30:00 AM
- MediPharm Labs Completes First Shipment to France • GlobeNewswire Inc. • 12/04/2025 01:40:00 PM
- MediPharm Announces Complete Dismissal of Defamation Action Initiated by Apollo, Nobul and Regan McGee Under Ontario Anti-SLAPP Law • GlobeNewswire Inc. • 11/14/2025 03:00:00 PM
- MediPharm Advances Global Reach in Q3 2025 with Double-Digit Revenue Growth and Strong International Medical Cannabis Gains • GlobeNewswire Inc. • 11/13/2025 01:00:00 PM
- MediPharm Labs Sets Date to Report Third Quarter 2025 Financial Results • GlobeNewswire Inc. • 11/10/2025 11:00:00 PM
